EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Exploring the Application of Contrast‐Enhanced Ultrasound in ACR BI‐RADS 4A Lesions (≤ 2 cm): A Prospective Multicenter Study in China

Xiaoyun Xiao iD, Wei Zhang iD, Xiaomao Luo iD, Yulan Peng iD, Yanling Zheng iD, Qi Zhou, Qiao Hu iD, Ying Zhu, Heng Zhang iD, Yinghua Li, Qing Zhou iD, Wen He iD und 1 weitere

The Breast Journal · 2026-01 · 2026 (1)

DOI: 10.1155/tbj/6622181 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift The Breast Journal, online erschienen am 13.03.2026. Verfasst von Xiaoyun Xiao und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ultrasound, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China, sysu.edu.cn. Hauptthemen laut MEDLINE: Contrast Media, Ultrasonography, Mammary, Breast Neoplasms. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To assess the added diagnostic value of contrast‐enhanced ultrasound (CEUS) in differentiating small breast lesions initially categorized as ACR BI‐RADS 4A. Materials and Methods A total of 1595 patients with small breast lesions (≤ 20 mm) from 37 tertiary hospitals were enrolled from August 2021 to August 2022. B‐mode ultrasound, color Doppler, and CEUS were performed to evaluate the lesions. The integration of CEUS led to the reclassification of BI‐RADS 4A lesions into three pathways: upgrade to 4B, downgrade to 3, or no change in category. The diagnostic performance of CEUS was evaluated, and the contrast modes which could be used to correctly downgrade or upgrade BI‐RADS 4A lesions were explored.

Results

A total of 1340 lesions were finally included in the analysis of CEUS performance. The average age of all included participants was 43 ± 8 (range from 20 to 84). The average diameter of the lesions was 12.4 ± 3.8 mm (range from 5 mm to 20 mm). The diagnostic performances of CEUS + BI‐RADS were 98.3% for sensitivity, 81.7% for specificity, 34.1% for positive predictive value, 99.8% for negative predictive value, and 83.1% for overall accuracy, respectively. The sensitivity was slightly downgraded (98.3% vs. 100%, p = 0.1555), while the specificity and accuracy were greatly elevated ( p < 0.05). The receiver operating characteristic curve (ROC) value was calculated using a binary classification threshold, with BI‐RADS 3 as low‐risk and BI‐RADS 4A as high‐risk. The area under ROC was 0.896 (95% CI: 0.878, 0.911) for BI‐RADS + CEUS. The decision curve analysis showed that using CEUS + BI‐RADS to guide biopsy decisions provided net benefit compared to the default strategy of biopsying all lesions.

Conclusion

The addition of CEUS allows for the correct downgrading of most benign BI‐RADS 4A lesions, thereby avoiding unnecessary biopsies. An upgrade from BI‐RADS 4A to 4B on CEUS warrants immediate biopsy to ensure prompt diagnosis and treatment. Trial Registration: Chinese Clinical Trial Registry: ChiCTR2100050719

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Contrast MediaUltrasonography, MammaryBreast NeoplasmsHumansFemaleProspective StudiesChinaMiddle AgedAdultAgedAged, 80 and overSensitivity and SpecificityYoung Adult

Stichwörter der Autor:innen

ACR BI-RADSbreastcontrast-enhanced ultrasoundneoplasmultrasonography

Substanzen

Contrast Media

Autor:innen und Institutionen

  • Department of Ultrasound, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China, sysu.edu.cn.
  • Department of Ultrasound, Beijing Tiantan Hospital, Capital Medical University, Beijing, China, ccmu.edu.cn.
  • Department of Ultrasound, Yunnan Cancer Hospital, The Third Affiliated Hospital of Kunming Medical University, Kunming, China, kmmc.cn.
  • Department of Ultrasound, West China Hospital, Sichuan University, Chengdu, China, scu.edu.cn.
  • Department of Ultrasound, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China, sysu.edu.cn.
  • Department of Ultrasound, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi an, China, xjtu.edu.cn.

ORCID-Profile: Xiaoyun Xiao, Wei Zhang, Xiaomao Luo, Yulan Peng, Yanling Zheng, Qiao Hu, Heng Zhang, Qing Zhou, Wen He, Baoming Luo

Zitieren

APA

Xiao, X., Zhang, W., Luo, X., Peng, Y., Zheng, Y., Zhou, Q., Hu, Q., Zhu, Y., Zhang, H., Li, Y., Zhou, Q., He, W., & Luo, B. (2026). Exploring the Application of Contrast‐Enhanced Ultrasound in ACR BI‐RADS 4A Lesions (≤ 2 cm): A Prospective Multicenter Study in China. The Breast Journal, 2026(1). https://doi.org/10.1155/tbj/6622181

Vancouver

Xiao X, Zhang W, Luo X, Peng Y, Zheng Y, Zhou Q, et al. Exploring the Application of Contrast‐Enhanced Ultrasound in ACR BI‐RADS 4A Lesions (≤ 2 cm): A Prospective Multicenter Study in China. The Breast Journal. 2026;2026(1). doi:10.1155/tbj/6622181

BibTeX
@article{Xiao2026,
  author = {Xiao, Xiaoyun and Zhang, Wei and Luo, Xiaomao and Peng, Yulan and Zheng, Yanling and Zhou, Qi and Hu, Qiao and Zhu, Ying and Zhang, Heng and Li, Yinghua and Zhou, Qing and He, Wen and Luo, Baoming},
  title = {Exploring the Application of Contrast‐Enhanced Ultrasound in ACR BI‐RADS 4A Lesions (≤ 2 cm): A Prospective Multicenter Study in China},
  journal = {The Breast Journal},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/tbj/6622181}
}
Kostenlos starten →